Exchange Bulletin

Sernova Corp. (SVA) To Trade On Toronto Stock Exchange

May 31, 2022
Issuer: Sernova Corp. (the "Company")
Security: Common shares ("Shares")
Symbol: SVA
Number of securities issued and outstanding: 275,624,662 Shares
Number of securities reserved for issuance: 87,502,296 Shares
Trading currency: CDN$
Listing and posted for trading date: June 2, 2022 (at the opening)
Listing category: Industrial, Non-Exempt Issuer
Other market(s): The Shares have been listed on TSX Venture Exchange ("TSXV") in their current form since September 20, 2006 under the symbol "SVA". The Shares will be delisted from TSXV on June 2, 2022 upon commencement of trading on Toronto Stock Exchange.
Temporary market maker: RBC Capital Markets
Security ownership registration: Certificated Issue
Investor relations: Corey Davis
LifeSci Advisors LLC
+1 (212) 915-2577
Christopher Barnes
VP, Investor Relations
+1 (519) 902-7923
Incorporation: Canada Business Corporations Act
Fiscal year end: October 31
Nature of business: The Company is a clinical-stage regenerative medicine cell therapeutics company focused on development and commercialization of its proprietary technologies, including Cell Pouch implantable device technologies and immune-protected therapeutic cells.
Transfer agent and registrar: TSX Trust Company at its principal offices in Vancouver and Toronto.
Dividends: None anticipated in the foreseeable future
Sponsorship: Not applicable
TSX contact: Anne Child,
TSX Listings